pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-122 |
Genomic Coordinates | chr18: 65248861 - 65248926 |
Synonyms | Mirn122a, mmu-mir-122, Mir122a |
Description | Mus musculus miR-122 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-122-5p |
Sequence | 6| UGGAGUGUGACAAUGGUGUUUG |27 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Ccng1 | ||||||||||||||||||||
Synonyms | AI314029 | ||||||||||||||||||||
Description | cyclin G1 | ||||||||||||||||||||
Transcript | NM_009831 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Ccng1 | |||||||||||||||||||||
3'UTR of Ccng1 (miRNA target sites are highlighted) |
>Ccng1|NM_009831|3'UTR 1 TTGATAAATCTGGTTGTTATTCTCTGTATACAGAAAATTTTCCAGTATGATCATTTTCTGCTACAACTGAAGAATTGAAA 81 TACTATCTTCAATATAAAGAATATGGGATGAAAACATAAAGGAAAAGTGAATTGTTGACTGGTCTAGATAGAGAATACTG 161 GAAGGCATTCACTGTGTACAGTGCGTAGCAGTTTTAAGAGAAAAGACATATCAAACCCCTAGATATACGCTAATACTTTT 241 CATCAAAAGATTAGCGTAGTAGCAAAGAGAATACTTTAAACTCGAATTTTAAAAGTAGTTACTGAAATAGCACTTCTTTA 321 AATTACGTACCACCCCACTGTAGCTTATTTAAAGTTGCATAAGCCCATGCAGAACAACAAGCAATGTGACCCATATATGA 401 ACAAATTTTAATCTGCCCATCGACTATGAAAATGAAGTACAAACCTGGGTGATGGACTTACAAAGTAATATAGGGCATGC 481 CCATGTTAGGTTTCTGGAAACTGCCAGAGTGTCTTAATTCTATAGCTAGTATTTTACCTCTATAGCATTTGGACTAATAC 561 AAAGTAATTATATGCATGAAAATATAAAATTGGTCTCTGATACATACACATTTTTGACATCTAAATTTCTTAATCATAGC 641 AAAGATTTATCTTTTTATGATTAAAAACAATTTTTTCCTTAATGCATGGCAGCACATGCCTTTAATCCCAGCACTAGAGA 721 GGCAGAGACAGGTAGATCTCTGAGTTCAAAGCCAGGCTGGTCTACACAGTGAGTTCCAAGACAGCTAGAGACCTTGTCTC 801 AAAAACACTCAAAACAACCAAACACCAGGGGTAAATGTTGCTGGGAAGTCAGGGAAGATGGTTTAGAAGGGAAGCCTGAC 881 AACCTGACTTCATTCTTCAGGACCCACATGATGGAAGGAGAGAACGAAGAACTCCCAAGTTCTCTCACATATGCACATAC 961 CTCACCACCCCCCGCAGGAAATACATGATCATGCGTCTGAGATATCACCAGTTCACCTTTAGCAGCTCGCAGTTTGTAGG 1041 CAGATTTCTGTTAAGTTGGGTCTGTGTTGTTTGCCTATGTAGCAGGATTACAGCAGCAGCAAAAACGGTCCCTCAAGTCT 1121 TTCTGCCACTCTGACCTGAGTTTCCTACGGTACAGGATTTACTCTGAGAAACCTCAGCACCTTGCCACAGTAGCCTTGGC 1201 AGAATGGCCTCACGGTTAGGGAAACTCCTGATTCTAAGCTTGGGAGAGCTACGCTTAGATTTGAATTCACCCAGGAAGCA 1281 TTCAAATCAAGGCTAAAGACATAAATGTGAAATAAAACTGTGAACCTTCATTCTAAAGTTCATCTGACTTCCCAGATTTG 1361 ATCAATATATTCTTAGGTGGTATTAAAAATGGTAAACTGCTTAATTTAAATCTCAAAATTTAAATTATGAGGTTTACATA 1441 AAAACCAACATTTCATGAATGCACTTTTAAGGTATTAAAAGGGGTACTTAAGCGGTAAATGGTTTCTTGGCACCCATAAC 1521 CAAGTAATAGTTAATTTACAGGTGGGATTTTTTTTTATTGCTATGAGAATTACATTTAAAATTGTGGGTGTTTTATATAA 1601 AGCAGATATCACAAGTTTTGAAAATTTGTTACCTTTAATATTTCTTCTAGAGAATAGGTGTTTGTATCCATAATAAAAGA 1681 AAAATTTGTCAGAACTGCTGCTTCAATCTAATCCCATTTGAGAGAATTGTCTTTACTGTCTTAATAACTGGATGAATTAT 1761 CACTCTGAAAATGTATTTATTGCACTAAAGTTAGTTTAGGCTTGATAAAACACTCCAGACATTTTTACTACAGACTGTTT 1841 CTATAAAACTGCCATTGCTTCTAATGGAGAATTTTATTTTAAAAGAAATAAAATTGCTGAGTTTATCTGCAAAACCTTTC 1921 TCTAAGTCTTATGGGACGTAAGGAGACACCTCCATAATTATAAGAGCCGTTGTGCTCAGAGTCTCCATGCTGGCTTGAAT 2001 GTATGATCCACACTGTTAAAACATAGGCAGCAGCTCAGGGCCCTGGACAGCCTGAGTCAACCTAGAGTAGCTGGAACCAT 2081 TTTGACATGTAATGGATAAGAAAATTATCCATTGAGAAGCTGAACAATAAACCAAAGAACGGGTGTATTTTATCCTTAAC 2161 CTCTGTAAACCACGTTACACTGAGAACACTTCAGTTCTTCCTAAAGGTTGATAGGCTTCAGTCTGAAAACAATATTGATT 2241 TGGAGTGGACAGAAGTTAACTAACCAACTACCATTATGTTTTGAATACACCTTTCAATAAAATGATTGAAATGCAAAAAA 2321 AAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Location of target site | 3'UTR |
Article |
- Esau C; Davis S; Murray SF; Yu XX; Pandey et al. - Cell metabolism, 2006
Current understanding of microRNA (miRNA) biology is limited, and antisense oligonucleotide (ASO) inhibition of miRNAs is a powerful technique for their functionalization. To uncover the role of the liver-specific miR-122 in the adult liver, we inhibited it in mice with a 2'-O-methoxyethyl phosphorothioate ASO. miR-122 inhibition in normal mice resulted in reduced plasma cholesterol levels, increased hepatic fatty-acid oxidation, and a decrease in hepatic fatty-acid and cholesterol synthesis rates. Activation of the central metabolic sensor AMPK was also increased. miR-122 inhibition in a diet-induced obesity mouse model resulted in decreased plasma cholesterol levels and a significant improvement in liver steatosis, accompanied by reductions in several lipogenic genes. These results implicate miR-122 as a key regulator of cholesterol and fatty-acid metabolism in the adult liver and suggest that miR-122 may be an attractive therapeutic target for metabolic disease.
LinkOut: [PMID: 16459310]
|
86 mmu-miR-122-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT003075 | Tmem50b | transmembrane protein 50B | 1 | 1 | ||||||||
MIRT003076 | Lass6 | ceramide synthase 6 | 1 | 1 | ||||||||
MIRT003077 | Gpx7 | glutathione peroxidase 7 | 1 | 1 | ||||||||
MIRT003113 | Tgfbr1 | transforming growth factor, beta receptor I | 3 | 1 | ||||||||
MIRT003114 | Sbk1 | SH3-binding kinase 1 | 3 | 1 | ||||||||
MIRT003117 | Hist1h1c | histone cluster 1, H1c | 3 | 1 | ||||||||
MIRT003118 | Ddc | dopa decarboxylase | 2 | 1 | ||||||||
MIRT003120 | Rell1 | RELT-like 1 | 3 | 1 | ||||||||
MIRT003121 | Bach1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 2 | 1 | ||||||||
MIRT003122 | Apob | apolipoprotein B | 2 | 1 | ||||||||
MIRT003123 | P4ha1 | procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide | 2 | 1 | ||||||||
MIRT003124 | Ccng1 | cyclin G1 | 2 | 1 | ||||||||
MIRT003125 | Slc7a1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | 3 | 3 | ||||||||
MIRT003126 | Gys1 | glycogen synthase 1, muscle | 2 | 2 | ||||||||
MIRT003127 | Slc35a4 | solute carrier family 35, member A4 | 2 | 2 | ||||||||
MIRT003128 | Hfe2 | hemochromatosis type 2 (juvenile) | 3 | 3 | ||||||||
MIRT003129 | Tmed3 | transmembrane p24 trafficking protein 3 | 2 | 2 | ||||||||
MIRT003132 | Bckdk | branched chain ketoacid dehydrogenase kinase | 4 | 1 | ||||||||
MIRT003133 | Aldoa | aldolase A, fructose-bisphosphate | 4 | 7 | ||||||||
MIRT003134 | Ndrg3 | N-myc downstream regulated gene 3 | 4 | 2 | ||||||||
MIRT003135 | Cd320 | CD320 antigen | 4 | 1 | ||||||||
MIRT003724 | Smarcd1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 3 | 1 | ||||||||
MIRT003725 | Rcan1 | regulator of calcineurin 1 | 2 | 1 | ||||||||
MIRT003726 | Gde1 | glycerophosphodiester phosphodiesterase 1 | 2 | 1 | ||||||||
MIRT004536 | Ccrn4l | nocturnin | 4 | 1 | ||||||||
MIRT005975 | Klf6 | Kruppel-like factor 6 | 4 | 1 | ||||||||
MIRT005976 | B2m | beta-2 microglobulin | 1 | 1 | ||||||||
MIRT005977 | Afp | alpha fetoprotein | 1 | 1 | ||||||||
MIRT005978 | Ccl2 | chemokine (C-C motif) ligand 2 | 1 | 1 | ||||||||
MIRT005979 | Csf3r | colony stimulating factor 3 receptor (granulocyte) | 1 | 1 | ||||||||
MIRT005980 | Ctgf | connective tissue growth factor | 1 | 1 | ||||||||
MIRT005981 | Cxcl13 | chemokine (C-X-C motif) ligand 13 | 1 | 1 | ||||||||
MIRT005982 | Cyp2b13 | cytochrome P450, family 2, subfamily b, polypeptide 13 | 1 | 1 | ||||||||
MIRT005983 | Dbp | D site albumin promoter binding protein | 1 | 1 | ||||||||
MIRT005984 | Igf2 | insulin-like growth factor 2 | 1 | 1 | ||||||||
MIRT005985 | Il1b | interleukin 1 beta | 1 | 1 | ||||||||
MIRT005986 | Jun | jun proto-oncogene | 1 | 1 | ||||||||
MIRT005987 | Per1 | period circadian clock 1 | 1 | 1 | ||||||||
MIRT005988 | Alpl | alkaline phosphatase, liver/bone/kidney | 2 | 1 | ||||||||
MIRT005989 | Cs | citrate synthase | 2 | 1 | ||||||||
MIRT005990 | Prom1 | prominin 1 | 3 | 1 | ||||||||
MIRT005991 | Sox4 | SRY (sex determining region Y)-box 4 | 3 | 1 | ||||||||
MIRT013527 | Uros | uroporphyrinogen III synthase | 1 | 1 | ||||||||
MIRT013528 | Ppox | protoporphyrinogen oxidase | 1 | 1 | ||||||||
MIRT013529 | Urod | uroporphyrinogen decarboxylase | 1 | 1 | ||||||||
MIRT013530 | Cpox | coproporphyrinogen oxidase | 1 | 1 | ||||||||
MIRT013531 | Fech | ferrochelatase | 1 | 1 | ||||||||
MIRT013532 | Hamp | hepcidin antimicrobial peptide | 1 | 1 | ||||||||
MIRT013533 | Tfr2 | transferrin receptor 2 | 1 | 1 | ||||||||
MIRT013534 | Smad4 | SMAD family member 4 | 1 | 1 | ||||||||
MIRT013535 | Smad7 | SMAD family member 7 | 1 | 1 | ||||||||
MIRT013536 | Bmpr1a | bone morphogenetic protein receptor, type 1A | 1 | 1 | ||||||||
MIRT013537 | Hba-a1 | hemoglobin alpha, adult chain 1 | 2 | 1 | ||||||||
MIRT013538 | Hmbs | hydroxymethylbilane synthase | 2 | 1 | ||||||||
MIRT013539 | Mir17 | microRNA 17 | 2 | 1 | ||||||||
MIRT013540 | Alas2 | aminolevulinic acid synthase 2, erythroid | 2 | 1 | ||||||||
MIRT013541 | Mir451 | microRNA 451a | 2 | 1 | ||||||||
MIRT013542 | Tfrc | transferrin receptor |